Rifaximin in Cirrhosis: Effects on Endotoxin and Haemostatic Indexes

NCT06630572 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Because drug is expired

Conditions

Liver Cirrhosis
Coagulation Disorder
Platelet Disorder
Endotoxemia

Interventions

DRUG: Rifaximin
DRUG: Placebo

Sponsor

University of Roma La Sapienza

Collaborators

[object Object]